Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Françoise, Renaud"'
Autor:
John O'Rourke, Claire L. Townsend, Edith Milanzi, Intira Jeannie Collins, Hannah Castro, Ali Judd, Marissa Vicari, Julie Jesson, Valériane Leroy, Martina Penazzato, Françoise Renaud
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and safety of T
Externí odkaz:
https://doaj.org/article/506a2793526a41bba159fa5b9a5617fe
Autor:
Claire L. Townsend, John O'Rourke, Edith Milanzi, Intira Jeannie Collins, Ali Judd, Hannah Castro, Marissa Vicari, Julie Jesson, Valériane Leroy, Françoise Renaud, Martina Penazzato
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction Globally about 1.7 million children were living with HIV in 2020. Two integrase strand transfer inhibitors, dolutegravir and raltegravir, are increasingly used in children. We conducted a systematic review to assess the effectiv
Externí odkaz:
https://doaj.org/article/97ab22fa53bd4558b5894ef106f79983
Autor:
Laura Saint-Lary, Marc Harris Dassi Tchoupa Revegue, Julie Jesson, Françoise Renaud, Martina Penazzato, Claire L. Townsend, John O'Rourke, Valériane Leroy, WHO HIV Hepatitis and STIs (HHS) Department
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundAtazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review to assess safety and effectiveness of atazanavir u
Externí odkaz:
https://doaj.org/article/18297fa7b565466eb628c43289b0646d
Autor:
Julie, Jesson, Laura, Saint-Lary, Marc Harris Dassi Tchoupa, Revegue, John, O'Rourke, Claire L, Townsend, Françoise, Renaud, Martina, Penazzato, Valériane, Leroy
Publikováno v:
The Lancet Child & Adolescent Health. 6:692-704
Abacavir is a nucleoside reverse transcriptase inhibitor recommended in paediatric HIV care. We assessed the safety and efficacy profile of abacavir used in first, second, or subsequent lines of treatment for infants, children, and adolescents living
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7dc1c9d1aed7add80969123ed742a95
https://doi.org/10.1016/s2352-4642(22)00213-9
https://doi.org/10.1016/s2352-4642(22)00213-9
Autor:
Françoise Renaud, Lynne M. Mofenson, Charlotte Bakker, Helen Dolk, Valeriane Leroy, Angelina Namiba, Leyla Sahin, Roger Shapiro, Amy Slogrove, Claire Thorne, Marissa Vicari, Daniel Low‐Beer, Meg Doherty
Publikováno v:
Journal of the International AIDS Society. 25
As new antiretrovirals (ARVs), including long-acting ARVs for treatment and prevention, are approved and introduced, surveillance during pregnancy must become the safety net for evaluating birth outcomes, especially those that are rare and require la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7677d35874a73ef71187e815ac20bdee
https://doi.org/10.1002/jia2.25922
https://doi.org/10.1002/jia2.25922
Autor:
Martina, Penazzato, Shahin, Lockman, Angela, Colbers, Françoise, Renaud, Alexandra, Calmy, Polly, Clayden, Marissa, Vicari, Imelda C, Mahaka, Jennifer M, Zech, Cadi, Irvine, Elaine J, Abrams
Publikováno v:
Journal of the International AIDS Society, 25 Suppl 2, Suppl 2
Journal of the International AIDS Society, 25 Suppl 2
Journal of the International AIDS Society, 25 Suppl 2
Contains fulltext : 283105.pdf (Publisher’s version ) (Open Access) INTRODUCTION: Historical approaches to clinical development of novel therapeutics for treatment and prevention of HIV have led to unacceptable delays in the generation of data to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec3235c0e508e2fd3fea633e1d33c3d
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/283105
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/283105
Autor:
Françoise Renaud-Théry, Carlos Avila-Figueroa, John Stover, Sigrid Thierry, Marco Vitoria, Vincent Habiyambere, Yves Souteyrand
Publikováno v:
AIDS Research and Treatment, Vol 2011 (2011)
Background. The rapid scale-up of antiretroviral therapy in resource-limited settings has greatly increased demand for antiretroviral medicines and raised the importance of good forward planning, especially in the context of the new 2010 WHO treatmen
Externí odkaz:
https://doaj.org/article/8dddac728e96417fb2308f9830cd2e5c
Autor:
Badara Samb, Boniface Dongmo Nguimfack, Marco Vitoria, Peter Graaff, Joseph H. Perriëns, Françoise Renaud-Théry, Evan Lee
Publikováno v:
AIDS. 21:S89-S95
Objective: To address the information gap on current use of antiretroviral drugs (ARTs) in developing countries. Methods: The AIDS Medicines and Diagnostics Service of the World Health Organization (WHO) carried out a multi-country survey in early 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab40907e5966fb5fe470a75f3b6b619
https://doi.org/10.1097/01.aids.0000279711.54922.f0
https://doi.org/10.1097/01.aids.0000279711.54922.f0
Autor:
Boniface Dongmo Nguimfack, Anil Soni, Robert Greener, Juan Pablo Gutiérrez, Omar Galárraga, Stefano M. Bertozzi, Megan E O'Brien, Katherine Waldman, Françoise Renaud-Théry, Michel Beusenberg
Publikováno v:
Web of Science
Background: Middle and low-income countries have scaled up HIV treatment in the past 5 years. To maintain this effort, information regarding the amounts and types of drugs is needed. Shortages or overstock of active pharmaceutical ingredients make th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50aff21478ef84feeb5b1d8a2dbaf527
https://doi.org/10.1097/01.aids.0000279712.32051.29
https://doi.org/10.1097/01.aids.0000279712.32051.29
Publikováno v:
Les Cahiers de l'INSEP. 32:244-266
Renaud Françoise, Yvequel Loïc, Zanibellato Cathy, Lehénaff Didier. Débat : Le sport féminin de haut niveau intéresse-t-il les sponsors ?. In: Les Cahiers de l'INSEP, n°32, 2002. Sport de haut niveau au féminin (tome II) pp. 244-266.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f5467b900d24a86500eedf31ce4029
https://doi.org/10.3406/insep.2002.1661
https://doi.org/10.3406/insep.2002.1661